OBJECTIVE—We examined the associations of physical activity with fasting plasma glucose (FPG) and with 2-h postload plasma glucose (2-h PG) in men and women with low, moderate, and high waist circumference.

RESEARCH DESIGN AND METHODS—The Australian Diabetes, Obesity and Lifestyle (AusDiab) study provided data on a population-based cross-sectional sample of 4,108 men and 5,106 women aged ≥25 years without known diabetes or health conditions that could affect physical activity. FPG and 2-h PG were obtained from an oral glucose tolerance test. Self-reported physical activity level was defined according to the current public health guidelines as active (≥150 min/week across five or more sessions) or inactive (<150 min/week and/or less than five sessions). Sex-specific quintiles of physical activity time were used to ascertain dose response.

RESULTS—Being physically active and total physical activity time were independently and negatively associated with 2-h PG. When physical activity level was considered within each waist circumference category, 2-h PG was significantly lower in active high–waist circumference women (β −0.30 [95% CI −0.59 to −0.01], P = 0.044) and active low–waist circumference men (β −0.25 [−0.49 to −0.02], P = 0.036) compared with their inactive counterparts. Considered across physical activity and waist circumference categories, 2-h PG levels were not significantly different between active moderate–waist circumference participants and active low–waist circumference participants. Associations between physical activity and FPG were nonsignificant.

CONCLUSIONS—There are important differences between 2-h PG and FPG related to physical activity. It appears that 2-h PG is more sensitive to the beneficial effects of physical activity, and these benefits occur across the waist circumference spectrum.

Over half of the adult Australian population is overweight or obese (1). Obesity is a major risk factor for insulin resistance and glucose intolerance, acknowledged recently by the term “diabesity,” which emphasizes the strong relationship between obesity and type 2 diabetes (2). However, despite the major public health and private sector interest in obesity, most adults have little success in maintaining long-term weight loss or preventing weight gain with aging (3).

Epidemiological and experimental evidence strongly supports the role of physical activity in reducing the risk of developing insulin resistance and glucose intolerance (4). Prospective studies have consistently shown that healthy-weight men and women who are physically active are at the lowest risk for developing type 2 diabetes, while obese inactive men and women are at the highest risk (58). Less well understood, however, is the risk of developing hyperglycemia in those who are overweight or obese but physically active or who are inactive but have a healthy weight. Clinical trials that include moderate levels of physical activity have shown improved insulin sensitivity among overweight adults, even without corresponding weight loss (9,10). However, few population-based studies have examined whether these clinical findings translate to a reduced risk of hyperglycemia among physically active overweight and obese adults compared with their inactive peers (58,1113), and none have used waist circumference, which reflects both total body fat and the distribution of excess body fat (14). Many of these studies are also limited by self-report of the presence of type 2 diabetes (6,11,12). Self-report of diabetes is inaccurate—it is estimated that half of prevalent cases of type 2 diabetes may be undiagnosed (15) and therefore cannot provide information on blood glucose levels. This is an important consideration, as elevated fasting and 2-h postload plasma glucose (2-h PG) levels, even those below the diabetic cutoff, have been associated with an increased risk of cardiovascular disease (16,17) and premature mortality (18).

Given the current obesity epidemic, it is important to understand the role of physical activity in reducing the risk of lifestyle-related disease in a population with an already high prevalence of overweight and obesity (1). Using data from the Australian Diabetes, Obesity and Lifestyle (AusDiab) study, we assessed the associations of physical activity with fasting plasma glucose (FPG) and 2-h PG concentrations in men and women of low, moderate, and high waist circumference. This study extends our previous work in this population that reported on the associations between physical activity and the categorical variables of abnormal glucose metabolism (19) and the metabolic syndrome (20). Because the physiological bases for FPG and 2-h PG concentrations are somewhat different (21), these two blood glucose measures were considered separately.

The 1999–2000 national, population-based cross-sectional AusDiab study was undertaken to estimate the prevalence of diabetes and its precursors in Australian adults aged ≥25 years. The methods, response rates, indications of the representativeness of the sample, and major findings of the AusDiab survey have been reported elsewhere in detail (1,15,22). The sample of 11,247 adults represented 55% of those completing the initial household interview (22). The present analysis uses data from 9,214 adults (4,108 men and 5,106 women) who took part in the biomedical examination, were not pregnant, and were without known diabetes. Participants who reported that their health limited them from performing moderate-intensity physical activities, as well as those who self-reported a history of angina, stroke, or myocardial infarction, were excluded from the analyses. The ethics committee of the International Diabetes Institute approved the AusDiab study design, and all participants provided written informed consent to participate.

After an overnight fast (minimum of 8 h), participants attended a local survey center where an oral glucose tolerance test was performed using World Health Organization specifications (23). Blood specimens were centrifuged and transported daily to the central laboratory where plasma glucose levels were determined (Olympus AU600 automated analyzer). Demographic attributes, parental history of diabetes, education (attended highest level of secondary school available yes/no), current cigarette smoking status (yes/no), television viewing time (hours per week), total household income (≥$1,500/week or <$1,500/week), alcohol intake (self-classified into nondrinker, light drinker, and moderate or heavy drinker), and menopausal status in women (gone/going through menopause yes/no) were assessed using an interviewer-administered questionnaire. Ethnicity was determined by place of birth and language spoken at home. Of responders, 87.9% were born in either Australia or the U.K., and 96% spoke English at home. Aboriginal and Torres Strait Islanders accounted for 0.8% of the total AusDiab sample (22).

Waist circumference was measured halfway between the lower border of the ribs and the iliac crest in the horizontal plane. Using a steel measuring tape, the mean of duplicate measures was used in the analyses. Reflecting increasing health risk (24), low, moderate, and high waist circumference categories were respectively defined as <94.0, 94.0–101.9, and ≥102 cm in men and <80.0, 80.0–87.9, and ≥88 cm in women (14).

Physical activity was measured by the Active Australia questionnaire, which asks respondents about their participation in predominantly leisure-time physical activities (including walking for transport) during the previous week (25). Total physical activity time was calculated as the sum of the time spent walking (if continuous and for ≥10 min) or performing moderate-intensity physical activity, plus double the time spent in vigorous-intensity physical activity (26). Frequency of physical activity was calculated by summing the number of sessions of vigorous activity, moderate activity, and walking. Physical activity was categorized to reflect the current Australian public health recommendation for physical activity (27) as active (≥150 min/week across at least five sessions) and inactive (<150 min/week and/or fewer than five sessions). Frequency of physical activity was included in the calculation of the physical activity variable because although a single bout of exercise can enhance glucose tolerance in the short-term (10), activity needs to be regular and sustained, as the beneficial effect on glucose metabolism disappears quickly once activity ceases (28).

Statistical analysis

All analyses were conducted using Stata Statistical Software Release 8.0 (29) survey commands for analyzing complex survey data. Sample weights based on the 1998 estimated residential Australian population were used to account for the clustering and stratification in the survey design and for nonresponse. Univariate analyses were used to compare physical activity groups for men and women. Sex-specific quintiles of physical activity time (minutes) were used to examine dose-response relationships between physical activity and plasma glucose concentration.

Multivariate linear regression analyses were performed to examine the independent and combined associations of physical activity and waist circumference with FPG and 2-h PG. Six separate multiple regression models, with the inactive group as the reference category, were used to assess the extent to which being active was associated with lower blood glucose within each of the three waist circumference categories for men and for women. To examine the association of physical activity with FPG and 2-h PG concentration across each waist circumference category, participants were categorized by both their physical activity (active or inactive) and their waist circumference (low, moderate, or high), with the active low–waist circumference group being the reference category. All multivariate regression analyses were adjusted for age, parental history of diabetes, cigarette smoking, alcohol intake, television time, income, education, and menopausal status (women only). Sex differences were tested for by interactions within the regression model.

Fifty-five percent of men and 64% of women did not meet the public health guidelines for physical activity. These physical activity levels are similar to those reported in the 1999 National Physical Activity Survey (26). The majority of participants (80% men and 83% women) had blood glucose readings in the normal range, while 3.4% of men and 2.9% of women were newly diagnosed with diabetes. When analyzed by physical activity category (Table 1), mean waist circumference and mean 2-h PG, but not FPG, levels were higher in inactive men and women compared with active men and women.

After adjusting for confounders, including waist circumference, meeting the public health guidelines for physical activity was independently associated with 2-h PG in both men (β −0.26 [95% CI −0.50 to −0.02], P = 0.037) and women (β −0.22 [−0.40 to −0.04], P = 0.016). However, the association between physical activity and FPG was nonsignificant (men P = 0.323, women P = 0.216) and remained nonsignificant after excluding waist circumference from the model (men P = 0.198, women P = 0.541). Having a moderate or high waist circumference was independently associated with a higher FPG and 2-h PG compared with those who had a low waist circumference (P for trend <0.001 for both men and women), with every 1-cm increase in waist circumference resulting in a 0.015- mmol/l (95% CI 0.01–0.08) and 0.012- mmol/l (0.01–0.02) increase in FPG, and a 0.04-mmol/l (0.03–0.05) and 0.03- mmol/l (0.02–0.04) increase in 2-h PG in men and women, respectively (P < 0.001 for all).

For each 30-min/day increase in physical activity time, 2-h PG reduced by 0.08 mmol/l (95% CI −0.13 to −0.02, P = 0.008) in men and 0.07 mmol/l in women (−0.12 to −0.01, P = 0.025), whereas the changes in FPG were nonsignificant. Figure 1 illustrates these dose-response relationships across quintiles of physical activity time. Although men had a higher FPG at each quintile of activity compared with women, there was no significant sex interaction for either FPG or 2-h PG.

Participants were categorized by both their physical activity and their waist circumference. Figure 2 presents the results from the multivariate regression analysis for FPG (Fig. 2A) and 2-h PG (Fig. 2B). When the association between physical activity and blood glucose was assessed within each of the three waist circumference categories, negligible differences in FPG concentration were observed in active men and women compared with inactive men and women, with differences <0.07 mmol/l. By contrast, being physically active was associated with significantly lower 2-h PG in low–waist circumference men (β −0.25 [95% CI −0.49 to −0.02], P = 0.036) and high–waist circumference women (β −0.30 [−0.59 to −0.01], P = 0.044) compared with their inactive counterparts, with nonsignificant negative associations observed in low–waist circumference women (β −0.18 [−0.45 to 0.09], P = 0.180), moderate–waist circumference men (β 0.17 [−0.63 to 0.30], P = 0.472) and women (β −0.17 [−0.51 to 0.17], P = 0.327), and high–waist circumference men (β −0.38 [−0.77 to 0.02], P = 0.061). When the association of physical activity with blood glucose was examined across each waist circumference category, it was observed that FPG values increased in a step-like progression across waist circumference categories with physical activity having negligible association with FPG. By contrast, a more linear relationship was observed for 2-h PG, implying that both physical activity and waist circumference are important for 2-h PG. In both sexes, 2-h PG levels in the active moderate–waist circumference category were not significantly different from 2-h PG levels in active participants with a low waist circumference. The pattern of change across the combined waist circumference and physical activity categories were similar for men and women with no significant sex interaction for either FPG or 2-h PG.

In this large, cross-sectional study of Australian adults, meeting the public health guideline for physical activity (≥150 min/week across five or more sessions) was independently associated with lower 2-h PG but not FPG. Similarly, a dose-response relationship was observed between physical activity and 2-h PG, but not FPG. When waist circumference and physical activity were considered simultaneously, being active was associated with significantly lower 2-h PG in high–waist circumference women and low–waist circumference men compared with their inactive counterparts. In addition, mean 2-h PG concentration in those with a moderate waist circumference who were active was not significantly different from those with a low waist circumference. Considering that the analyses were conducted on a large subset of the total AusDiab study sample (22), these findings are likely to have high generalizability to the broader Australian adult population.

The association of physical activity with 2-h PG but not FPG is consistent with previous work in this area (3032). However, previous observations are restricted to an intervention study of 18 overweight women (30), an intervention on 88 Dutch adults at increased risk for developing diabetes (31), and a cross-sectional study on the unique, high-risk Pima-Indian population (32). This is the first study to have described this association in a large, nationally representative Caucasian population. The finding that moderate levels of physical activity were associated with lower 2-h PG values, even in men and women with moderate or high waist circumference, could have important public health implications. While nondiabetic levels of both FPG and 2-h PG are independently associated with cardiovascular disease (17), compared with FPG, 2-h PG is considered to be more predictive of all-cause and cardiovascular mortality (33). Fasting hyperglycemia and 2-h postload hyperglycemia have related but differing physiological bases. Both are instances of insulin resistance (or reduced sensitivity); however, the relevant sites of insulin resistance differ between these measures. Fasting hyperglycemia predominantly reflects hepatic insulin resistance with normal muscle insulin sensitivity; postload hyperglycemia is characterized by moderate-to-severe skeletal muscle insulin resistance with normal or mildly reduced hepatic insulin sensitivity (34). This might explain the association with 2-h PG but not FPG in our study, since physical activity is directly associated with improved insulin sensitivity (35,36). Furthermore, the absence of an association with FPG concurs with the findings from controlled clinical studies in people with and without type 2 diabetes who have generally observed no changes in FPG following exercise training (3739).

Despite the success of lifestyle interventions (that included increasing physical activity and reducing weight) in improving glucose tolerance and reducing the risk of developing type 2 diabetes in high-risk individuals (32,40,41), few population-based studies have examined the extent to which regular physical activity can attenuate the risk of hyperglycemia that is associated with overweight and obesity. In studies using self-reported physician-diagnosed diabetes as an outcome measure, physical activity typically had a relatively small impact, with the risk of diabetes in the overweight and obese groups significantly greater than in those in the lowest body fat category regardless of activity level (6,1113). The effect of physical activity is more pronounced, however, when diabetes is determined objectively. In the Aerobic Centre Longitudinal Study, fit obese men had a similar risk of incident diabetes as unfit nonobese men (8), while active Pima Indian women in the second BMI tertile had a similar risk of incident diabetes as inactive women in the lowest BMI tertile (7). We found that in all waist circumference categories, mean 2-h PG values were lower in those who were active compared with those who were inactive. Concentration of 2-h PG did not significantly differ between those who were active and had either a low or moderate waist circumference. These results add to the current “fitness versus fatness” debate in suggesting that physical activity attenuates the risk of having high blood glucose associated with elevated waist circumference. However, the linear relationship between 2-h PG and the joint physical activity and waist circumference categories emphasizes that waist circumference remains an important factor in blood glucose control.

When the association between physical activity and blood glucose was considered within each waist circumference category, the lower 2-h PG values associated with meeting the public health guidelines for physical activity were particularly evident among high–waist circumference women and low–waist circumference men. Previous prospective studies that have explored the relationship between physical activity and blood glucose within categories of body fat have typically reported that the greatest benefit of physical activity was observed in men and women who were overweight or obese, with a nonsignificant effect observed in men and women in the leanest group (11,12,42). The current findings suggest that meeting the public health guideline for physical activity is important not just for those with a moderate or high waist circumference but also for men with a low waist circumference. This has important implications for screening individuals at risk for hyperglycemia. For example, the Australian evidence-based guidelines for the management of type 2 diabetes do not currently include physical activity as a factor to identify who should be tested for undiagnosed type 2 diabetes (43). Inclusion of a physical activity measure in the screening guidelines would help capture the group of men with a low waist circumference who are inactive and who may have a significantly increased risk of higher 2-h PG compared with their active peers.

This is the first study in a large, representative population-based sample to have examined the combined associations of physical activity and waist circumference with blood glucose in men and women. Its major strengths include a large sample size across a wide age range, objective measures of glucose status, detailed anthropometric measurements, and a comprehensive lifestyle assessment. Limitations include the cross-sectional design and the self-report of physical activity. The Active Australia questionnaire and model were used to measure and categorize physical activity based on current public health recommendations concerning duration and frequency of physical activity (27). Although the validity and reliability of the Active Australia questionnaire is acceptable (44,45), in general, questionnaires give only a crude and imprecise estimate of habitual physical activity and misclassification is inevitable. To obtain more accurate data on physical activity, future research should aim to collect objective measures of physical activity, such as accelerometer data (46). Although we found a significant dose-response relationship between physical activity duration and 2-h PG, further work is required to elucidate what particular types, intensities, and settings for physical activity may be most beneficial to improving blood glucose control in men and women with an elevated waist circumference.

Over half of the population that we studied had a moderate or high waist circumference. Although maintaining a healthy weight is important to maintain normoglycemia, weight loss is difficult and time consuming. Meeting the public health guidelines for physical activity may provide a feasible strategy for improving blood glucose control in those who already have an elevated waist circumference. The advantages of using physical activity as an intervention are that it is nonpharmacological and that the direct beneficial effects of physical activity on glucose tolerance and insulin sensitivity are rapid (10). Long-term physical activity can also indirectly decrease 2-h PG and FPG concentrations through weight loss and prevention of weight gain (8,47), which also leads to improved insulin sensitivity (48). While only a prospective study can determine the combined contributions of physical activity and waist circumference to the development of prediabetes and type 2 diabetes, the prospective collection of physical activity data in this population will eventually allow for such an evaluation.

Given the current “diabesity” epidemic, improving the understanding of the association of physical activity with blood glucose in low–, moderate–, and high–waist circumference men and women is both relevant and timely. This large, representative, population-based study highlights that there are important differences between 2-h PG and FPG in relation to physical activity. Our findings demonstrate that 2-h PG appears to be more sensitive than FPG to the beneficial effects of physical activity and that these benefits appear across the waist circumference spectrum.

Figure 1—

Dose-response relationship between sex-specific quintiles of physical activity duration (minutes) and fasting plasma glucose (A) and 2-h PG (B) for men (▴) and women (□). Marginal means (95% CI) adjusted for age, parental history of diabetes, smoking, waist circumference, alcohol intake, education, income, menopause status (women), and television time.

Figure 1—

Dose-response relationship between sex-specific quintiles of physical activity duration (minutes) and fasting plasma glucose (A) and 2-h PG (B) for men (▴) and women (□). Marginal means (95% CI) adjusted for age, parental history of diabetes, smoking, waist circumference, alcohol intake, education, income, menopause status (women), and television time.

Close modal
Figure 2—

Linear regression coefficients and 95% CI for fasting plasma glucose (A) and 2-h PG (B) in men (▴) and women (□) within categories of physical activity (active or inactive) and waist circumference (low, moderate, or high). Coefficients adjusted for age, parental history of diabetes, smoking, alcohol intake, education, income, menopause status (women), and television time. *Statistically significant differences between active and inactive groups within the waist circumference category. Reference values: FPG men 5.37 mmol/l, women 5.09 mmol/l; 2-h PG men 5.47 mmol/l, women 5.56 mmol/l.

Figure 2—

Linear regression coefficients and 95% CI for fasting plasma glucose (A) and 2-h PG (B) in men (▴) and women (□) within categories of physical activity (active or inactive) and waist circumference (low, moderate, or high). Coefficients adjusted for age, parental history of diabetes, smoking, alcohol intake, education, income, menopause status (women), and television time. *Statistically significant differences between active and inactive groups within the waist circumference category. Reference values: FPG men 5.37 mmol/l, women 5.09 mmol/l; 2-h PG men 5.47 mmol/l, women 5.56 mmol/l.

Close modal
Table 1—

Selected characteristics of men and women in the AusDiab study according to physical activity category

CharacteristicSexInactive (n = 5,463)Active (n = 3,751)P value
n (within sex) 2,211 (55) 1,897 (45)  
 3,252 (64) 1,854 (36)  
Age (years) 45.49 (43.96–47.01) 45.02 (43.39–46.65) 0.559 
 47.44 (45.64–49.23) 46.04 (44.03–48.05) 0.090 
FPG (mmol/l) 5.55 (5.51–5.59) 5.49 (5.43–5.56) 0.159 
 5.26 (5.21–5.30) 5.23 (5.18–5.27) 0.640 
2-h PG (mmol/l) 6.04 (5.85–6.22) 5.71 (5.58–5.85) 0.008 
 6.28 (6.13–6.43) 5.86 (5.66–6.06) 0.002 
Waist circumference (cm) 95.98 (94.93–97.03) 94.73 (93.52–95.94) 0.036 
 83.72 (81.94–85.47) 81.31 (79.39–83.23) 0.007 
Low waist circumference 44.67 (820) 49.19 (872) 0.099 
 43.87 (1,248) 51.16 (871) 0.019 
Moderate waist circumference 29.28 (687) 27.67 (502) 0.341 
 23.69 (795) 23.16 (444) 0.919 
High waist circumference 26.04 (704) 23.14 (523) 0.146 
 32.44 (1209) 25.68 (539) 0.007 
Parental history of diabetes 17.03 (379) 13.86 (292) 0.032 
 19.76 (619) 18.17 (362) 0.230 
Gone/going through menopause 43.29 (1,662) 38.84 (887) 0.431 
Current cigarette smoker 19.71 (412) 18.42 (305) 0.524 
 14.26 (479) 13.86 (251) 0.543 
Television viewing time (h/week) 13.28 (12.36–14.21) 12.71 (12.06–13.37) 0.240 
 11.71 (10.86–12.55) 10.88 (10.11–11.66) 0.184 
Completed highest level of education available 51.39 (1,042) 53.66 (1,010) 0.471 
 47.45 (1,461) 51.66 (953) 0.076 
Alcohol abstainers 13.35 (272) 9.23 (178) 0.050 
 20.16 (577) 14.42 (275) 0.006 
Household income ≥$1,500/week 19.56 (432) 23.46 (437) 0.145 
 15.44 (473) 19.19 (343) 0.180 
CharacteristicSexInactive (n = 5,463)Active (n = 3,751)P value
n (within sex) 2,211 (55) 1,897 (45)  
 3,252 (64) 1,854 (36)  
Age (years) 45.49 (43.96–47.01) 45.02 (43.39–46.65) 0.559 
 47.44 (45.64–49.23) 46.04 (44.03–48.05) 0.090 
FPG (mmol/l) 5.55 (5.51–5.59) 5.49 (5.43–5.56) 0.159 
 5.26 (5.21–5.30) 5.23 (5.18–5.27) 0.640 
2-h PG (mmol/l) 6.04 (5.85–6.22) 5.71 (5.58–5.85) 0.008 
 6.28 (6.13–6.43) 5.86 (5.66–6.06) 0.002 
Waist circumference (cm) 95.98 (94.93–97.03) 94.73 (93.52–95.94) 0.036 
 83.72 (81.94–85.47) 81.31 (79.39–83.23) 0.007 
Low waist circumference 44.67 (820) 49.19 (872) 0.099 
 43.87 (1,248) 51.16 (871) 0.019 
Moderate waist circumference 29.28 (687) 27.67 (502) 0.341 
 23.69 (795) 23.16 (444) 0.919 
High waist circumference 26.04 (704) 23.14 (523) 0.146 
 32.44 (1209) 25.68 (539) 0.007 
Parental history of diabetes 17.03 (379) 13.86 (292) 0.032 
 19.76 (619) 18.17 (362) 0.230 
Gone/going through menopause 43.29 (1,662) 38.84 (887) 0.431 
Current cigarette smoker 19.71 (412) 18.42 (305) 0.524 
 14.26 (479) 13.86 (251) 0.543 
Television viewing time (h/week) 13.28 (12.36–14.21) 12.71 (12.06–13.37) 0.240 
 11.71 (10.86–12.55) 10.88 (10.11–11.66) 0.184 
Completed highest level of education available 51.39 (1,042) 53.66 (1,010) 0.471 
 47.45 (1,461) 51.66 (953) 0.076 
Alcohol abstainers 13.35 (272) 9.23 (178) 0.050 
 20.16 (577) 14.42 (275) 0.006 
Household income ≥$1,500/week 19.56 (432) 23.46 (437) 0.145 
 15.44 (473) 19.19 (343) 0.180 

Data are weighted to the Australian population and are means (95% CI) or % (n). Inactive: <150 min/week and/or less than five sessions; active: ≥150min/week and five or more sessions. P value adjusted for age.

The following provided financial support: Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp & Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, HITECH Pathology, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia (Northern Territory), Queensland Health, South Australian Department of Human Services, Tasmanian Department of Human Services, Victorian Department of Human Services, and Health Department of Western Australia.

G.N.H. is supported by an Australian Postgraduate Award. D.W.D. is supported by a Victorian Health Promotion Foundation Public Health Research Fellowship. N.O. is supported by Queensland Health Core Research Infrastructure grant and by NHMRC Program grant funding.

We thank A. Allman, B. Atkins, S. Bennett, S. Chadban, S. Colagiuri, M. de Courten, M. Dalton, M. D’Embden, T. Dwyer, D. Jolley, I. Kemp, P. Magnus, J. Mathews, D. McCarty, A. Meehan, K. O’Dea, P. Phillips, P. Popplewell, C. Reid, A. Stewart, R. Tapp, H. Taylor, T. Welborn, and F. Wilson for their invaluable contribution to the set up and field activities of AusDiab.

1.
Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, Dalton M, Jolley D, Shaw JE: Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab).
Med J Aust
178
:
427
–432,
2003
2.
Astrup A, Finer N: Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’?
Obes Rev
1
:
57
–59,
2000
3.
Crawford D, Jeffery RW, French SA: Can anyone successfully control their weight? Findings of a three year community-based study of men and women.
Int J Obes Relat Metab Disord
24
:
1107
–1110,
2000
4.
Ivy JL: Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
Sports Med
24
:
321
–336,
1997
5.
Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J: Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.
Arch Intern Med
164
:
892
–896,
2004
6.
Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, Gaziano JM: Relationship of physical activity vs body mass index with type 2 diabetes in women.
JAMA
292
:
1188
–1194,
2004
7.
Kriska AM, Saremi A, Hanson RL, Bennett PH, Kobes S, Williams DE, Knowler WC: Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population.
Am J Epidemiol
158
:
669
–675,
2003
8.
Wei M, Schwertner HA, Blair SN: The association between physical activity, physical fitness, and type 2 diabetes mellitus.
Compr Ther
26
:
176
–182,
2000
9.
Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW: Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults.
Diabetes Care
26
:
557
–562,
2003
10.
Angelopoulos TJ, Schultz RM, Denton JC, Jamurtas AZ: Significant enhancements in glucose tolerance and insulin action in centrally obese subjects following ten days of training.
Clin J Sport Med
12
:
113
–118,
2002
11.
Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.
N Engl J Med
325
:
147
–152,
1991
12.
Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH: A prospective study of exercise and incidence of diabetes among US male physicians.
JAMA
268
:
63
–67,
1992
13.
Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO: Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000–2002.
Diabetes Care
28
:
1599
–1603,
2005
14.
Lean ME, Han TS, Morrison CE: Waist circumference as a measure for indicating need for weight management.
BMJ
311
:
158
–161,
1995
15.
Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE, the AusDiab Steering Committee: The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.
Diabetes Care
25
:
829
–834,
2002
16.
Levitan EB, Song Y, Ford ES, Liu S: Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.
Arch Intern Med
164
:
2147
–2155,
2004
17.
Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
Diabetes Care
22
:
233
–240,
1999
18.
The DECODE Study Group, the European Diabetes Epidemiology Group: Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
Diabetes Care
26
:
688
–696,
2003
19.
Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA, Cameron AJ, Dwyer T, Jolley D, Shaw JE, AusDiab Steering Committee: Physical activity and television viewing in relation to risk of undiagnosed abnormal glucose metabolism in adults.
Diabetes Care
27
:
2603
–2609,
2004
20.
Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA, Cameron AJ, Dwyer T, Jolley D, Shaw JE: Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults.
Diabetologia
48
:
2254
–2261,
2005
21.
Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Diabet Med
19
:
708
–723,
2002
22.
Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab): methods and response rates.
Diabetes Res Clin Pract
57
:
119
–129,
2002
23.
World Health Organization:
Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus
. Geneva, World Health Org.,
1999
24.
Janssen I, Katzmarzyk PT, Ross R: Waist circumference and not body mass index explains obesity-related health risk.
Am J Clin Nutr
79
:
379
–384,
2004
25.
Australian Institute of Health and Welfare:
The Active Australia Survey: A Guide and Manual for Implementation, Analysis and Reporting
. Canberra, Australia, Australia Institute of Health and Welfare,
2003
26.
Armstrong T, Bauman A, Davies J:
Physical Activity Patterns of Australian Adults: Results of the 1999 National Physical Activity Survey
. Canberra, Australia, Australian Institute of Health and Welfare,
2000
(AIHW cat. no. CVD 10)
27.
Commonwealth Department of Health and Aged Care:
National Physical Activity Guidelines for Australians
. Canberra, Australia, Department of Health and Aged Care,
1999
28.
Heath GW, Gavin JR 3rd, Hinderliter JM, Hagberg JM, Bloomfield SA, Holloszy JO: Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity.
J Appl Physiol
55
:
512
–517,
1983
29.
Stata Corp:
Statistical Software: Release 8.0
. College Station, TX, Stata,
2003
30.
Swartz AM, Strath SJ, Bassett DR, Moore JB, Redwine BA, Groer M, Thompson DL: Increasing daily walking improves glucose tolerance in overweight women.
Prev Med
37
:
356
–362,
2003
31.
Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ: Lifestyle intervention according to general recommendations improves glucose tolerance.
Obes Res
11
:
1588
–1596,
2003
32.
Kriska AM, LaPorte RE, Pettitt DJ, Charles MA, Nelson RG, Kuller LH, Bennett PH, Knowler WC: The association of physical activity with obesity, fat distribution and glucose intolerance in Pima Indians.
Diabetologia
36
:
863
–869,
1993
33.
The DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.
Arch Intern Med
161
:
397
–405,
2001
34.
Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
Diabetes Care
29
:
1130
–1139,
2006
35.
Mayer-Davis EJ, D’Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN: Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
JAMA
279
:
669
–674,
1998
36.
Kriska AM, Pereira MA, Hanson RL, de Courten MP, Zimmet PZ, Alberti KG, Chitson P, Bennett PH, Narayan KM, Knowler WC: Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI.
Diabetes Care
24
:
1175
–1180,
2001
37.
Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE: Effect of the volume and intensity of exercise training on insulin sensitivity.
J Appl Physiol
96
:
101
–106,
2004
38.
Rice B, Janssen I, Hudson R, Ross R: Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
Diabetes Care
22
:
684
–691,
1999
39.
Dunstan DW, Daly RM, Owen N, Jolley D, De Courten M, Shaw J, Zimmet P: High-intensity resistance training improves glycemic control in older patients with type 2 diabetes.
Diabetes Care
25
:
1729
–1736,
2002
40.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
N Engl J Med
346
:
393
–403,
2002
41.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med
344
:
1343
–1350,
2001
42.
Folsom AR, Kushi LH, Hong CP: Physical activity and incident diabetes mellitus in postmenopausal women.
Am J Public Health
90
:
134
–138,
2000
43.
The Australian Centre for Diabetes Strategies:
National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus
. Canberra, Australia, Australian Government National Health and Medical Research Council,
2001
44.
Brown W, Bauman A, Timperio A, Salmon J, Trost SG:
Measurement of Adult Physical Activity: Reliability, Comparison and Validity of Self-Report Surveys for Population Surveillance: Summary and Recommendations
. Canberra, Australia, Department of Health and Ageing,
2002
45.
Brown WJ, Trost SG, Bauman A, Mummery K, Owen N: Test-retest reliability of four physical activity measures used in population surveys.
J Sci Med Sport
7
:
205
–215,
2004
46.
Kumahara H, Schutz Y, Ayabe M, Yoshioka M, Yoshitake Y, Shindo M, Ishii K, Tanaka H: The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry.
Br J Nutr
91
:
235
–243,
2004
47.
Blair SN: Evidence for success of exercise in weight loss and control.
Ann Intern Med
119
:
702
–706,
1993
48.
Greenfield JR, Campbell LV: Insulin resistance and obesity.
Clin Dermatol
22
:
289
–295,
2004

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.